TB 500 5 mg
Main Image

TB 500 5 mg

Steroids British Dragon Pharmaceuticals British

$24.00

British Dragon TB 500 5 mg – Thymosin Beta-4 for Tissue Repair Research

✔ High-purity lyophilized powder ✔ 5 mg per 2 mL vial ✔ Naturally occurring repair peptide ✔ USA & International shipping

British Dragon TB 500 5 mg is a synthetic version of Thymosin Beta-4, a naturally occurring peptide involved in wound healing, cell migration, and inflammation modulation. Each 2 mL vial contains 5 mg of lyophilized TB-500, ready for reconstitution for research applications involving soft tissue repair, angiogenesis, and recovery processes.

TB-500 has gained recognition in research circles for its ability to promote actin regulation, cell proliferation, and blood vessel formation. Unlike traditional growth factors, TB-500 works through multiple pathways including upregulation of matrix metalloproteinases and anti-apoptotic mechanisms. Explore similar research compounds like BPC 157 5 mg or GHK-CU 50 mg.

What Makes British Dragon TB 500 Unique?

TB-500's primary mechanism involves binding to actin, a key structural protein in cells, which facilitates cell migration, proliferation, and differentiation. This actin-sequestering property distinguishes TB-500 from most other repair-focused peptides and underlies its effects on wound closure, scar reduction, and tissue remodeling.

For researchers investigating recovery acceleration, TB-500 is often studied alongside BPC-157 for synergistic effects on soft tissue repair. The 5 mg dosage and extended half-life make it suitable for twice-weekly administration protocols. Researchers may also combine TB-500 with BPC 157 to evaluate comprehensive tissue regeneration models.

Benefits of British Dragon TB 500 for Research

  • ✔ Supports wound healing and tissue repair research
  • ✔ Promotes angiogenesis and cell migration studies
  • ✔ 5 mg lyophilized powder for flexible dosing
  • ✔ Suitable for subcutaneous administration research
  • ✔ Can be stacked with BPC-157 for comprehensive repair protocols
Research Grade

British Dragon TB 500 5 mg is intended for laboratory research only. Not for human consumption or clinical use.

External research on TB-500's mechanisms can be explored via PubMed for peer-reviewed studies.

Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:
Brand: British Dragon Pharmaceuticals
Manufacturer: British Dragon Pharmaceuticals
Dosage Info: <div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel"> <section class="tab-panel" id="panel-usage"> <h2>Dosage &amp; Usage Guidelines for Research</h2> <div class="info-card warning"> <p><strong>For laboratory research use only.</strong> Not for human consumption. Reconstitution and handling must be performed by qualified personnel using sterile techniques.</p> </div> <h3>Reconstitution Protocol</h3> <ul class="usage-highlights"> <li>✔ Add 2-3 mL bacteriostatic water to the 5 mg vial</li> <li>✔ Swirl gently; do not shake</li> <li>✔ Store reconstituted peptide at 2-8°C and use within 30 days</li> </ul> <p>The standard reconstitution yields a concentration of approximately 1.67-2.5 mg/mL depending on the volume used. For precise dosing, researchers should calculate based on desired mg per injection volume.</p> <h3>Typical Research Parameters</h3> <p>In animal models, TB-500 is often administered at dosages ranging from 2.5-5 mg per week, typically divided into 2-3 injections due to its 2-3 day half-life. Subcutaneous injection is the standard route for systemic tissue repair research.</p> <ul> <li>✔ Subcutaneous injection: 1-2.5 mg per injection, 2-3 times weekly</li> <li>✔ Research models: Dosing typically scaled by body weight</li> <li>✔ Study duration: 2-6 weeks for tissue remodeling studies</li> </ul> <h3>Combination Research</h3> <p>TB-500 is frequently studied alongside BPC-157 for synergistic effects on soft tissue repair, wound healing, and inflammation reduction. This combination targets complementary pathways in tissue regeneration research. For stacking protocols, <a href="/british-dragon-2079/bpc-157-5-mg-90945">BPC 157 5 mg</a> can be reconstituted and administered on an alternating schedule.</p> <div class="info-card"> <p><strong>Note:</strong> Dosages mentioned are for research purposes only. Individual response varies in animal models. Always follow institutional animal care guidelines when conducting in vivo research.</p> </div> <h3>What to Avoid During Research</h3> <ul> <li>❌ Do not use if the lyophilized cake appears discolored or collapsed</li> <li>❌ Avoid exposure to high heat or direct light</li> <li>❌ Do not mix with strong solvents or extreme pH solutions</li> <li>❌ Avoid repeated freeze-thaw cycles after reconstitution</li> </ul> </section> </div>
Reviews:
(0 customer reviews)

Technical Details

Peptide Type
Endogenous Actin-Binding Peptide
Peptide Sequence
SDKPDMAEIEKFDKSKLKKTETQEKNTLPTKETIEQEKQAGES
Peptide Length
43 Amino-Acid Residues
Terminal Form
N-Terminal Acetylated Peptide
Molecular Formula
C₂₁₂H₃₅₀N₅₆O₇₈S
Molecular Weight
4963.4 g/mol
CAS Number
77591-33-4
PubChem CID
16132379
Primary Binding Partner
G-Actin
Biological Function
Actin Monomer Sequestration
Actin-Binding Region
LKKTETQ · Residues 17–22

Chat on WhatsApp